Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality.

MLA

Bozkurt, Süreyya, et al. “Aggressive Clinicopathological Course of Myeloma with t(3;16) (Q21;Q22) Cytogenetic Abnormality.” Turkish Journal of Hematology, vol. 36, no. 1, Jan. 2019, pp. 62–63. EBSCOhost, https://doi.org/10.4274/tjh.galenos.2018.2018.0197.

APA

Bozkurt, S., Okay, M., & Haznedaroğlu, İ. (2019). Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality. Turkish Journal of Hematology, 36(1), 62–63. https://doi.org/10.4274/tjh.galenos.2018.2018.0197

Chicago

Bozkurt, Süreyya, Müfide Okay, and İbrahim Haznedaroğlu. 2019. “Aggressive Clinicopathological Course of Myeloma with t(3;16) (Q21;Q22) Cytogenetic Abnormality.” Turkish Journal of Hematology 36 (1): 62–63. doi:10.4274/tjh.galenos.2018.2018.0197.